Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis
We investigated whether red blood cell distribution width (RDW) predicts vasculitis activity based on Birmingham vasculitis activity score (BVAS) or BVAS for granulomatosis with polyangiitis (GPA) at diagnosis and poor prognosis during follow-up in patients with antineutrophil cytoplasmic antibody (...
Saved in:
Published in | Yonsei medical journal Vol. 59; no. 2; pp. 294 - 302 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Yonsei University College of Medicine
01.03.2018
연세대학교의과대학 |
Subjects | |
Online Access | Get full text |
ISSN | 0513-5796 1976-2437 1976-2437 |
DOI | 10.3349/ymj.2018.59.2.294 |
Cover
Loading…
Abstract | We investigated whether red blood cell distribution width (RDW) predicts vasculitis activity based on Birmingham vasculitis activity score (BVAS) or BVAS for granulomatosis with polyangiitis (GPA) at diagnosis and poor prognosis during follow-up in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
We reviewed the medical records of 150 patients with AAV. We defined severe GPA as BVAS for GPA ≥7 (the highest quartile). Correlation and standardised correlation coefficients were analysed by linear regression tests. The differences between groups were evaluated by Mann-Whitney test. Relative risk (RR) was assessed by chi square test and Cox hazards model.
RDW was correlated only with the vasculitis activity of GPA among patients with AAV. An increase in RDW was associated with the absence of ear nose throat (ENT) manifestation, but not proteinase 3-ANCA. Significant differences were noted in cumulative refractory free survival according to RDW ≥15.4% (p=0.007) and the absence of ENT manifestation (p=0.036). Multivariate Cox hazards analysis identified RDW ≥15.4% as the only significant predictor of refractory disease in GPA (RR 17.573).
RDW predicts vasculitis activity in GPA, and RDW ≥15.4% at diagnosis may increase the risk of severe GPA at diagnosis and predict refractory diseases during follow-up. |
---|---|
AbstractList | Purpose: We investigated whether red blood cell distribution width (RDW) predicts vasculitis activity based on Birmingham vasculitisactivity score (BVAS) or BVAS for granulomatosis with polyangiitis (GPA) at diagnosis and poor prognosis during follow-up in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
Materials and Methods: We reviewed the medical records of 150 patients with AAV. We defined severe GPA as BVAS for GPA ≥7 (the highest quartile). Correlation and standardised correlation coefficients were analysed by linear regression tests. The differences between groups were evaluated by Mann-Whitney test. Relative risk (RR) was assessed by chi square test and Cox hazards model.
Results: RDW was correlated only with the vasculitis activity of GPA among patients with AAV. An increase in RDW was associatedwith the absence of ear nose throat (ENT) manifestation, but not proteinase 3-ANCA. Significant differences were noted in cumulativerefractory free survival according to RDW ≥15.4% (p=0.007) and the absence of ENT manifestation (p=0.036). MultivariateCox hazards analysis identified RDW ≥15.4% as the only significant predictor of refractory disease in GPA (RR 17.573).
Conclusion: RDW predicts vasculitis activity in GPA, and RDW ≥15.4% at diagnosis may increase the risk of severe GPA at diagnosisand predict refractory diseases during follow-up. KCI Citation Count: 1 We investigated whether red blood cell distribution width (RDW) predicts vasculitis activity based on Birmingham vasculitis activity score (BVAS) or BVAS for granulomatosis with polyangiitis (GPA) at diagnosis and poor prognosis during follow-up in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).PURPOSEWe investigated whether red blood cell distribution width (RDW) predicts vasculitis activity based on Birmingham vasculitis activity score (BVAS) or BVAS for granulomatosis with polyangiitis (GPA) at diagnosis and poor prognosis during follow-up in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).We reviewed the medical records of 150 patients with AAV. We defined severe GPA as BVAS for GPA ≥7 (the highest quartile). Correlation and standardised correlation coefficients were analysed by linear regression tests. The differences between groups were evaluated by Mann-Whitney test. Relative risk (RR) was assessed by chi square test and Cox hazards model.MATERIALS AND METHODSWe reviewed the medical records of 150 patients with AAV. We defined severe GPA as BVAS for GPA ≥7 (the highest quartile). Correlation and standardised correlation coefficients were analysed by linear regression tests. The differences between groups were evaluated by Mann-Whitney test. Relative risk (RR) was assessed by chi square test and Cox hazards model.RDW was correlated only with the vasculitis activity of GPA among patients with AAV. An increase in RDW was associated with the absence of ear nose throat (ENT) manifestation, but not proteinase 3-ANCA. Significant differences were noted in cumulative refractory free survival according to RDW ≥15.4% (p=0.007) and the absence of ENT manifestation (p=0.036). Multivariate Cox hazards analysis identified RDW ≥15.4% as the only significant predictor of refractory disease in GPA (RR 17.573).RESULTSRDW was correlated only with the vasculitis activity of GPA among patients with AAV. An increase in RDW was associated with the absence of ear nose throat (ENT) manifestation, but not proteinase 3-ANCA. Significant differences were noted in cumulative refractory free survival according to RDW ≥15.4% (p=0.007) and the absence of ENT manifestation (p=0.036). Multivariate Cox hazards analysis identified RDW ≥15.4% as the only significant predictor of refractory disease in GPA (RR 17.573).RDW predicts vasculitis activity in GPA, and RDW ≥15.4% at diagnosis may increase the risk of severe GPA at diagnosis and predict refractory diseases during follow-up.CONCLUSIONRDW predicts vasculitis activity in GPA, and RDW ≥15.4% at diagnosis may increase the risk of severe GPA at diagnosis and predict refractory diseases during follow-up. We investigated whether red blood cell distribution width (RDW) predicts vasculitis activity based on Birmingham vasculitis activity score (BVAS) or BVAS for granulomatosis with polyangiitis (GPA) at diagnosis and poor prognosis during follow-up in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). We reviewed the medical records of 150 patients with AAV. We defined severe GPA as BVAS for GPA ≥7 (the highest quartile). Correlation and standardised correlation coefficients were analysed by linear regression tests. The differences between groups were evaluated by Mann-Whitney test. Relative risk (RR) was assessed by chi square test and Cox hazards model. RDW was correlated only with the vasculitis activity of GPA among patients with AAV. An increase in RDW was associated with the absence of ear nose throat (ENT) manifestation, but not proteinase 3-ANCA. Significant differences were noted in cumulative refractory free survival according to RDW ≥15.4% (p=0.007) and the absence of ENT manifestation (p=0.036). Multivariate Cox hazards analysis identified RDW ≥15.4% as the only significant predictor of refractory disease in GPA (RR 17.573). RDW predicts vasculitis activity in GPA, and RDW ≥15.4% at diagnosis may increase the risk of severe GPA at diagnosis and predict refractory diseases during follow-up. |
Author | Lee, Sang-Won Jung, Seung Min Song, Jason Jungsik Park, Yong-Beom Kim, Ho Jae Yoo, Juyoung |
AuthorAffiliation | 2 Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Korea 1 Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea |
AuthorAffiliation_xml | – name: 2 Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Korea – name: 1 Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea |
Author_xml | – sequence: 1 givenname: Ho Jae orcidid: 0000-0003-4471-8949 surname: Kim fullname: Kim, Ho Jae organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea – sequence: 2 givenname: Juyoung surname: Yoo fullname: Yoo, Juyoung organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea – sequence: 3 givenname: Seung Min surname: Jung fullname: Jung, Seung Min organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea – sequence: 4 givenname: Jason Jungsik surname: Song fullname: Song, Jason Jungsik organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea – sequence: 5 givenname: Yong-Beom surname: Park fullname: Park, Yong-Beom organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea – sequence: 6 givenname: Sang-Won orcidid: 0000-0002-8038-3341 surname: Lee fullname: Lee, Sang-Won organization: Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea., Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29436199$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002316235$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9kUtvEzEUhS1URNPAD2CDvITFDH7M-LFBCgFKpUpEVYGl5fF4UrcTu7U9hfx7nKRUwAJ5cSXf75xj-ZyAIx-8BeAlRjWljXy73VzXBGFRt7ImNZHNEzDDkrOKNJQfgRlqMa1aLtkxOEnpGiHCMSLPwHFBKcNSzsDPC9vD92MIPVzacYQfXMrRdVN2wcPvrs9XcKk9XEXbO5PhN53MNLrsElyY7O5d3kLte7gKIRYorH1IZec8PI3aT2PY6Ly_-eGK0yqMW-3Xbqd_Dp4Oekz2xcOcg6-fPl4uP1fnX07PlovzyjSU5ko3LedGYmJE3xtLOyxIbxosWd8xWw7r-KAxli1rxIB0x1BrJe-JtaxloqFz8Obg6-OgboxTQbv9XAd1E9Xi4vJMESa4lLyw7w7s7dRtbInzOepR3Ua30XG7V_698e6q-NyrVhAqKC0Grx8MYribbMpq45Ip_6q9DVNSBCEssRCUFPTVn1mPIb-rKQA-ACaGlKIdHhGM1K5-VepXu_pVKxXZC-eA_6MxLutdl-W5bvyP8hddDbfh |
CitedBy_id | crossref_primary_10_21518_ms2024_290 crossref_primary_10_1186_s12883_023_03219_1 crossref_primary_10_3349_ymj_2021_62_4_279 crossref_primary_10_1016_j_ejr_2019_06_001 crossref_primary_10_3389_fmed_2022_945011 crossref_primary_10_3349_ymj_2019_60_1_10 crossref_primary_10_1080_00325481_2025_2454216 crossref_primary_10_31083_j_rcm2404109 |
Cites_doi | 10.2217/bmm-2016-0148 10.1038/nrrheum.2010.158 10.1002/art.39450 10.1002/art.37715 10.1371/journal.pone.0105436 10.1016/j.amjcard.2009.09.027 10.1016/j.semnephrol.2006.06.001 10.3899/jrheum.160005 10.1002/art.1780330803 10.1016/0736-4679(91)90592-4 10.1093/rheumatology/keu345 10.1146/annurev-pathol-011811-132453 10.1136/ard.2006.054593 10.1007/s00296-017-3706-5 10.1002/art.39812 10.1038/nrrheum.2016.123 10.1002/art.1780330806 10.1111/cei.12796 10.1002/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5 10.1371/journal.pone.0167000 10.1371/journal.pone.0068780 10.1371/journal.pone.0080240 10.1111/liv.12868 10.1136/ard.2008.101279 10.1002/art.1780330807 10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A 10.1097/MD.0b013e318205a4c6 10.1111/1756-185X.13144 10.1177/0300060515591063 |
ContentType | Journal Article |
Copyright | Copyright: Yonsei University College of Medicine 2018 Copyright: Yonsei University College of Medicine 2018 2018 Yonsei University College of Medicine |
Copyright_xml | – notice: Copyright: Yonsei University College of Medicine 2018 – notice: Copyright: Yonsei University College of Medicine 2018 2018 Yonsei University College of Medicine |
DBID | AAYXX CITATION NPM 7X8 5PM ACYCR |
DOI | 10.3349/ymj.2018.59.2.294 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1976-2437 |
EndPage | 302 |
ExternalDocumentID | oai_kci_go_kr_ARTI_2687997 PMC5823833 29436199 10_3349_ymj_2018_59_2_294 |
Genre | Journal Article |
GroupedDBID | --- .55 .GJ 123 29R 2WC 36B 5-W 53G 5RE 8JR 8XY 9ZL AAYXX ACYCR ADBBV ADRAZ AEGXH AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION CS3 DIK DU5 E3Z EBD EF. EMB EMOBN F5P GROUPED_DOAJ GX1 HYE KQ8 L7B M48 MK0 O5R O5S OK1 OVT P2P PGMZT RNS RPM SV3 TR2 X7M XSB ZGI ZXP M~E NPM 7X8 5PM |
ID | FETCH-LOGICAL-c433t-a4577c912c8ddce3b182dc4196db6e6e66b7fa1195648f0ab605e97d2ee656843 |
IEDL.DBID | M48 |
ISSN | 0513-5796 1976-2437 |
IngestDate | Sun Mar 09 07:52:32 EDT 2025 Thu Aug 21 18:28:54 EDT 2025 Fri Jul 11 11:54:29 EDT 2025 Wed Feb 19 02:43:06 EST 2025 Tue Jul 01 04:03:10 EDT 2025 Thu Apr 24 23:01:37 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | granulomatosis with polyangiitis vasculitis activity score prognosis ANCA-associated vasculitis Red blood cell distribution width |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c433t-a4577c912c8ddce3b182dc4196db6e6e66b7fa1195648f0ab605e97d2ee656843 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 https://www.eymj.org/DOIx.php?id=10.3349/ymj.2018.59.2.294 |
ORCID | 0000-0003-4471-8949 0000-0002-8038-3341 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3349/ymj.2018.59.2.294 |
PMID | 29436199 |
PQID | 2001918832 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_2687997 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5823833 proquest_miscellaneous_2001918832 pubmed_primary_29436199 crossref_primary_10_3349_ymj_2018_59_2_294 crossref_citationtrail_10_3349_ymj_2018_59_2_294 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-03-01 |
PublicationDateYYYYMMDD | 2018-03-01 |
PublicationDate_xml | – month: 03 year: 2018 text: 2018-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Yonsei medical journal |
PublicationTitleAlternate | Yonsei Med J |
PublicationYear | 2018 |
Publisher | Yonsei University College of Medicine 연세대학교의과대학 |
Publisher_xml | – name: Yonsei University College of Medicine – name: 연세대학교의과대학 |
References | Jennette (10.3349/ymj.2018.59.2.294_ref1) 2013; 65 Nangaku (10.3349/ymj.2018.59.2.294_ref23) 2006; 26 Gayraud (10.3349/ymj.2018.59.2.294_ref9) 2001; 44 Miloslavsky (10.3349/ymj.2018.59.2.294_ref30) 2016; 68 Masi (10.3349/ymj.2018.59.2.294_ref5) 1990; 33 Dabbah (10.3349/ymj.2018.59.2.294_ref25) 2010; 105 Koma (10.3349/ymj.2018.59.2.294_ref27) 2013; 8 Bloch (10.3349/ymj.2018.59.2.294_ref2) 1990; 33 Yoo (10.3349/ymj.2018.59.2.294_ref19) 2017; 35 Leavitt (10.3349/ymj.2018.59.2.294_ref4) 1990; 33 Watts (10.3349/ymj.2018.59.2.294_ref3) 2007; 66 Mukhtyar (10.3349/ymj.2018.59.2.294_ref6) 2009; 68 Evans (10.3349/ymj.2018.59.2.294_ref11) 1991; 9 Jennette (10.3349/ymj.2018.59.2.294_ref24) 2013; 8 Chen (10.3349/ymj.2018.59.2.294_ref21) 2010; 6 Oh (10.3349/ymj.2018.59.2.294_ref18) 2017; 37 de Groot (10.3349/ymj.2018.59.2.294_ref8) 2001; 55 Mukhtyar (10.3349/ymj.2018.59.2.294_ref22) 2006; 24 Lorente (10.3349/ymj.2018.59.2.294_ref26) 2014; 9 Kemna (10.3349/ymj.2018.59.2.294_ref29) 2016; 185 Aksoy (10.3349/ymj.2018.59.2.294_ref15) 2015; 43 Oh (10.3349/ymj.2018.59.2.294_ref16) 2017; 35 Luo (10.3349/ymj.2018.59.2.294_ref12) 2016; 11 Puéchal (10.3349/ymj.2018.59.2.294_ref28) 2016; 68 Guillevin (10.3349/ymj.2018.59.2.294_ref10) 2011; 90 Yoo (10.3349/ymj.2018.59.2.294_ref17) 2017; 20 Tecer (10.3349/ymj.2018.59.2.294_ref14) 2016; 10 Lee (10.3349/ymj.2018.59.2.294_ref32) 2016; 36 Chen (10.3349/ymj.2018.59.2.294_ref33) 2013; 8 Stone (10.3349/ymj.2018.59.2.294_ref7) 2001; 44 Cornec (10.3349/ymj.2018.59.2.294_ref20) 2016; 12 Furuta (10.3349/ymj.2018.59.2.294_ref31) 2017; 44 Rodríguez-Carrio (10.3349/ymj.2018.59.2.294_ref13) 2015; 54 17083770 - Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-93-8 11200865 - Clin Nephrol. 2001 Jan;55(1):31-8 25966326 - Liver Int. 2016 Jan;36(1):24-30 27564580 - Biomark Med. 2016 Sep;10 (9):967-74 23347350 - Annu Rev Pathol. 2013 Jan 24;8:139-60 28766857 - Int J Rheum Dis. 2017 Oct;20(10 ):1593-1605 26473755 - Arthritis Rheumatol. 2016 Mar;68(3):690-701 23045170 - Arthritis Rheum. 2013 Jan;65(1):1-11 11263782 - Arthritis Rheum. 2001 Mar;44(3):666-75 2202307 - Arthritis Rheum. 1990 Aug;33(8):1094-100 16949463 - Semin Nephrol. 2006 Jul;26(4):261-8 21200183 - Medicine (Baltimore). 2011 Jan;90(1):19-27 20102941 - Am J Cardiol. 2010 Feb 1;105(3):312-7 27936006 - PLoS One. 2016 Dec 9;11(12 ):e0167000 19054820 - Ann Rheum Dis. 2009 Dec;68(12):1827-32 16901958 - Ann Rheum Dis. 2007 Feb;66(2):222-7 20924413 - Nat Rev Rheumatol. 2010 Nov;6(11):653-64 24244659 - PLoS One. 2013 Nov 11;8(11):e80240 23874760 - PLoS One. 2013 Jul 17;8(7):e68780 26359293 - J Int Med Res. 2015 Dec;43(6):765-73 25153089 - PLoS One. 2014 Aug 25;9(8):e105436 2202308 - Arthritis Rheum. 1990 Aug;33(8):1101-7 25239880 - Rheumatology (Oxford). 2015 Apr;54(4):641-6 27464484 - Nat Rev Rheumatol. 2016 Oct;12 (10 ):570-9 28339364 - Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):111-118 28341881 - Rheumatol Int. 2017 May;37(5):685-694 11318006 - Arthritis Rheum. 2001 Apr;44(4):912-20 2202306 - Arthritis Rheum. 1990 Aug;33(8):1068-73 1955687 - J Emerg Med. 1991;9 Suppl 1:71-4 27803133 - J Rheumatol. 2017 Feb;44(2):216-222 28134074 - Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):47-54 27428559 - Arthritis Rheumatol. 2016 Dec;68(12 ):2945-2952 27009928 - Clin Exp Immunol. 2016 Aug;185(2):141-7 |
References_xml | – volume: 10 start-page: 967 year: 2016 ident: 10.3349/ymj.2018.59.2.294_ref14 publication-title: Biomark Med doi: 10.2217/bmm-2016-0148 – volume: 55 start-page: 31 year: 2001 ident: 10.3349/ymj.2018.59.2.294_ref8 publication-title: Clin Nephrol – volume: 6 start-page: 653 year: 2010 ident: 10.3349/ymj.2018.59.2.294_ref21 publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2010.158 – volume: 68 start-page: 690 year: 2016 ident: 10.3349/ymj.2018.59.2.294_ref28 publication-title: Arthritis Rheumatol doi: 10.1002/art.39450 – volume: 65 start-page: 1 year: 2013 ident: 10.3349/ymj.2018.59.2.294_ref1 publication-title: Arthritis Rheum doi: 10.1002/art.37715 – volume: 9 start-page: e105436 year: 2014 ident: 10.3349/ymj.2018.59.2.294_ref26 publication-title: PLoS One doi: 10.1371/journal.pone.0105436 – volume: 105 start-page: 312 year: 2010 ident: 10.3349/ymj.2018.59.2.294_ref25 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2009.09.027 – volume: 26 start-page: 261 year: 2006 ident: 10.3349/ymj.2018.59.2.294_ref23 publication-title: Semin Nephrol doi: 10.1016/j.semnephrol.2006.06.001 – volume: 44 start-page: 216 year: 2017 ident: 10.3349/ymj.2018.59.2.294_ref31 publication-title: J Rheumatol doi: 10.3899/jrheum.160005 – volume: 33 start-page: 1068 year: 1990 ident: 10.3349/ymj.2018.59.2.294_ref2 publication-title: Arthritis Rheum doi: 10.1002/art.1780330803 – volume: 9 start-page: 71 issue: Suppl 1 year: 1991 ident: 10.3349/ymj.2018.59.2.294_ref11 publication-title: J Emerg Med doi: 10.1016/0736-4679(91)90592-4 – volume: 54 start-page: 641 year: 2015 ident: 10.3349/ymj.2018.59.2.294_ref13 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keu345 – volume: 8 start-page: 139 year: 2013 ident: 10.3349/ymj.2018.59.2.294_ref24 publication-title: Annu Rev Pathol doi: 10.1146/annurev-pathol-011811-132453 – volume: 66 start-page: 222 year: 2007 ident: 10.3349/ymj.2018.59.2.294_ref3 publication-title: Ann Rheum Dis doi: 10.1136/ard.2006.054593 – volume: 37 start-page: 685 year: 2017 ident: 10.3349/ymj.2018.59.2.294_ref18 publication-title: Rheumatol Int doi: 10.1007/s00296-017-3706-5 – volume: 68 start-page: 2945 year: 2016 ident: 10.3349/ymj.2018.59.2.294_ref30 publication-title: Arthritis Rheumatol doi: 10.1002/art.39812 – volume: 12 start-page: 570 year: 2016 ident: 10.3349/ymj.2018.59.2.294_ref20 publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2016.123 – volume: 33 start-page: 1094 year: 1990 ident: 10.3349/ymj.2018.59.2.294_ref5 publication-title: Arthritis Rheum doi: 10.1002/art.1780330806 – volume: 185 start-page: 141 year: 2016 ident: 10.3349/ymj.2018.59.2.294_ref29 publication-title: Clin Exp Immunol doi: 10.1111/cei.12796 – volume: 44 start-page: 912 year: 2001 ident: 10.3349/ymj.2018.59.2.294_ref7 publication-title: Arthritis Rheum doi: 10.1002/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5 – volume: 11 start-page: e0167000 year: 2016 ident: 10.3349/ymj.2018.59.2.294_ref12 publication-title: PLoS One doi: 10.1371/journal.pone.0167000 – volume: 8 start-page: e68780 year: 2013 ident: 10.3349/ymj.2018.59.2.294_ref33 publication-title: PLoS One doi: 10.1371/journal.pone.0068780 – volume: 24 start-page: S93 issue: 6 Suppl 43 year: 2006 ident: 10.3349/ymj.2018.59.2.294_ref22 publication-title: Clin Exp Rheumatol – volume: 8 start-page: e80240 year: 2013 ident: 10.3349/ymj.2018.59.2.294_ref27 publication-title: PLoS One doi: 10.1371/journal.pone.0080240 – volume: 35 start-page: 111 issue: Suppl 103 year: 2017 ident: 10.3349/ymj.2018.59.2.294_ref19 publication-title: Clin Exp Rheumatol – volume: 36 start-page: 24 year: 2016 ident: 10.3349/ymj.2018.59.2.294_ref32 publication-title: Liver Int doi: 10.1111/liv.12868 – volume: 68 start-page: 1827 year: 2009 ident: 10.3349/ymj.2018.59.2.294_ref6 publication-title: Ann Rheum Dis doi: 10.1136/ard.2008.101279 – volume: 33 start-page: 1101 year: 1990 ident: 10.3349/ymj.2018.59.2.294_ref4 publication-title: Arthritis Rheum doi: 10.1002/art.1780330807 – volume: 35 start-page: 47 issue: Suppl 103 year: 2017 ident: 10.3349/ymj.2018.59.2.294_ref16 publication-title: Clin Exp Rheumatol – volume: 44 start-page: 666 year: 2001 ident: 10.3349/ymj.2018.59.2.294_ref9 publication-title: Arthritis Rheum doi: 10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A – volume: 90 start-page: 19 year: 2011 ident: 10.3349/ymj.2018.59.2.294_ref10 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0b013e318205a4c6 – volume: 20 start-page: 1593 year: 2017 ident: 10.3349/ymj.2018.59.2.294_ref17 publication-title: Int J Rheum Dis doi: 10.1111/1756-185X.13144 – volume: 43 start-page: 765 year: 2015 ident: 10.3349/ymj.2018.59.2.294_ref15 publication-title: J Int Med Res doi: 10.1177/0300060515591063 – reference: 1955687 - J Emerg Med. 1991;9 Suppl 1:71-4 – reference: 21200183 - Medicine (Baltimore). 2011 Jan;90(1):19-27 – reference: 28766857 - Int J Rheum Dis. 2017 Oct;20(10 ):1593-1605 – reference: 24244659 - PLoS One. 2013 Nov 11;8(11):e80240 – reference: 20102941 - Am J Cardiol. 2010 Feb 1;105(3):312-7 – reference: 25966326 - Liver Int. 2016 Jan;36(1):24-30 – reference: 2202306 - Arthritis Rheum. 1990 Aug;33(8):1068-73 – reference: 25153089 - PLoS One. 2014 Aug 25;9(8):e105436 – reference: 2202308 - Arthritis Rheum. 1990 Aug;33(8):1101-7 – reference: 11200865 - Clin Nephrol. 2001 Jan;55(1):31-8 – reference: 23347350 - Annu Rev Pathol. 2013 Jan 24;8:139-60 – reference: 11263782 - Arthritis Rheum. 2001 Mar;44(3):666-75 – reference: 19054820 - Ann Rheum Dis. 2009 Dec;68(12):1827-32 – reference: 26359293 - J Int Med Res. 2015 Dec;43(6):765-73 – reference: 28341881 - Rheumatol Int. 2017 May;37(5):685-694 – reference: 17083770 - Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-93-8 – reference: 27428559 - Arthritis Rheumatol. 2016 Dec;68(12 ):2945-2952 – reference: 26473755 - Arthritis Rheumatol. 2016 Mar;68(3):690-701 – reference: 27009928 - Clin Exp Immunol. 2016 Aug;185(2):141-7 – reference: 23045170 - Arthritis Rheum. 2013 Jan;65(1):1-11 – reference: 23874760 - PLoS One. 2013 Jul 17;8(7):e68780 – reference: 27564580 - Biomark Med. 2016 Sep;10 (9):967-74 – reference: 16949463 - Semin Nephrol. 2006 Jul;26(4):261-8 – reference: 25239880 - Rheumatology (Oxford). 2015 Apr;54(4):641-6 – reference: 27464484 - Nat Rev Rheumatol. 2016 Oct;12 (10 ):570-9 – reference: 28339364 - Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):111-118 – reference: 2202307 - Arthritis Rheum. 1990 Aug;33(8):1094-100 – reference: 20924413 - Nat Rev Rheumatol. 2010 Nov;6(11):653-64 – reference: 27936006 - PLoS One. 2016 Dec 9;11(12 ):e0167000 – reference: 27803133 - J Rheumatol. 2017 Feb;44(2):216-222 – reference: 16901958 - Ann Rheum Dis. 2007 Feb;66(2):222-7 – reference: 28134074 - Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):47-54 – reference: 11318006 - Arthritis Rheum. 2001 Apr;44(4):912-20 |
SSID | ssj0027102 |
Score | 2.2082298 |
Snippet | We investigated whether red blood cell distribution width (RDW) predicts vasculitis activity based on Birmingham vasculitis activity score (BVAS) or BVAS for... Purpose: We investigated whether red blood cell distribution width (RDW) predicts vasculitis activity based on Birmingham vasculitisactivity score (BVAS) or... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 294 |
SubjectTerms | Original 의학일반 |
Title | Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29436199 https://www.proquest.com/docview/2001918832 https://pubmed.ncbi.nlm.nih.gov/PMC5823833 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002316235 |
Volume | 59 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Yonsei Medical Journal, 2018, 59(2), , pp.294-302 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfWISFeEN_LgMognpBSWtv58ANCozAGUtGEKNubFX9kC8scyFJp_e-5S9JCUYVQHiLFZzv2nXP3sy93hLxILZPGMRGOOWeYwoyF0jkROpHZ3FiZm3a_Y_Y5PpqLT6fR6Q5ZpbfqJ_BqK7TDfFLzuhxd_1y-gQX_GhEnF_LV8vI7-milo0iO2IhJMSA3QDHFKOQzkf7GX5PWBRHEkIf4C2Z3yLm9iQ01NfB1vs0C_duR8g_NdHiH3O5NSnrQycBdsuP8PXJz1h-a3yfXX5ylb9FBnU5dWdJ3GCu3T3NFTwrbnNNp5ulxjTUa-q31TcVQR_TAdLklaOYtPa6qGogq9MyDssLTD6DnFmUFNm_7BLd0gapcZv6swPoPyPzw_dfpUdgnXAiN4LwJMxEliZETZlILY-IawIc1Ahap1bGDK9ZJnmGQuFik-TjTgIWcTCxzDszCVPCHZNdX3u0Rmifc8cxKDfaHEInRbqJjbY3OMwFP0oCMV_OrTB-NHJNilApQCbJEAUsUskRFUjEFLAnIy3WVH10ojn8RPwemqQtTKAygjfezSl3UCmDCR8XiNJEyCcizFU8VrCo8Ksm8qxZXmJwTgGwKn7uAPOp4vO4TWucAO2VAkg3urwmww80SX5y3kbujFCwkzvf_5-Uek1s4os7f7QnZbeqFewoGUKOHZBCFJ8N2-2DYivgvXXMHKA |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Red+Blood+Cell+Distribution+Width+Can+Predict+Vasculitis+Activity+and+Poor+Prognosis+in+Granulomatosis+with+Polyangiitis&rft.jtitle=Yonsei+medical+journal&rft.au=%EA%B9%80%ED%98%B8%EC%9E%AC&rft.au=%EC%9C%A0%EC%A3%BC%EC%98%81&rft.au=%EC%A0%95%EC%8A%B9%EB%AF%BC&rft.au=%EC%86%A1%EC%A0%95%EC%8B%9D&rft.date=2018-03-01&rft.pub=%EC%97%B0%EC%84%B8%EB%8C%80%ED%95%99%EA%B5%90%EC%9D%98%EA%B3%BC%EB%8C%80%ED%95%99&rft.issn=0513-5796&rft.eissn=1976-2437&rft.spage=294&rft.epage=302&rft_id=info:doi/10.3349%2Fymj.2018.59.2.294&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_2687997 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0513-5796&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0513-5796&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0513-5796&client=summon |